Publication:
Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial

Simple item page
dc.contributor.authorPanaccione, R.
dc.contributor.authorColombel, J-F.
dc.contributor.authorBossuyt, P.
dc.contributor.authorBaert, F.
dc.contributor.authorVanasek, T.
dc.contributor.authorDanalioglu, A.
dc.contributor.authorNovacek, G.
dc.contributor.authorArmuzzi, A.
dc.contributor.authorReinisch, W.
dc.contributor.authorJohnson, S.
dc.contributor.authorBuessing, M.
dc.contributor.authorNeimark, E.
dc.contributor.authorPetersson, J.
dc.contributor.authorRobinson, A. M.
dc.contributor.authorThakkar, R. B.
dc.contributor.authorLee, W-J.
dc.contributor.authorSkup, M.
dc.contributor.authorD'Haens, G.
dc.date.accessioned2020-10-22T21:41:30Z
dc.date.available2020-10-22T21:41:30Z
dc.date.issued2018-02-01T00:00:00Z
dc.identifier.citationPanaccione R., Colombel J., Bossuyt P., Baert F., Vanasek T., Danalioglu A., Novacek G., Armuzzi A., Reinisch W., Johnson S., et al., -Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial-, JOURNAL OF CROHNS & COLITIS, cilt.12, 2018
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25000
dc.identifier.wosWOS:000427318900104
dc.titleLong-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial
dc.typeArticle
dspace.entity.typePublication
local.avesis.idff9b3f68-f3ae-4d4a-9ae5-fbb15a283430
local.publication.isinternational1
Files
Collections
Yayınlar - Eserler